(Total Views: 420)
Posted On: 09/04/2025 3:03:00 PM
Post# of 158162
Re: biloxiblues #156604
RFK said there was a LC project funded by NIH which spent a lot of money but it yielded nothing. It sounds like RECOVER is dead.
RFK mentioned one other doctor: Dr. Jordan Vaughn. Here is a summary of what ChatGPT said about him:
Dr. Vaughn has treated approximately 1,500–1,600 Long COVID patients, incorporating combinations of blood thinners (antiplatelet agents, anticoagulants) and supplements. Many patients reportedly experienced significant symptom relief.
Vaughn collaborates with notable researchers such as Resia Pretorius, Jaco Laubscher, and Douglas Kell. While his treatments are currently based on clinical observation and protocols, he has expressed interest in launching clinical trials to rigorously test his methods.
Dr. Vaughn treats Long COVID as a vascular (endothelial) disease, focusing on how the SARS-CoV-2 spike protein can cause endothelial damage and microvascular clotting (microclots), impairing oxygen delivery throughout the body.
While many patients report improvement, his methods remain largely outside mainstream clinical research and are not yet validated through published clinical trials or peer-reviewed studies.
RFK mentioned one other doctor: Dr. Jordan Vaughn. Here is a summary of what ChatGPT said about him:
Dr. Vaughn has treated approximately 1,500–1,600 Long COVID patients, incorporating combinations of blood thinners (antiplatelet agents, anticoagulants) and supplements. Many patients reportedly experienced significant symptom relief.
Vaughn collaborates with notable researchers such as Resia Pretorius, Jaco Laubscher, and Douglas Kell. While his treatments are currently based on clinical observation and protocols, he has expressed interest in launching clinical trials to rigorously test his methods.
Dr. Vaughn treats Long COVID as a vascular (endothelial) disease, focusing on how the SARS-CoV-2 spike protein can cause endothelial damage and microvascular clotting (microclots), impairing oxygen delivery throughout the body.
While many patients report improvement, his methods remain largely outside mainstream clinical research and are not yet validated through published clinical trials or peer-reviewed studies.
(3)
(0)
